You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Potent inhibitor of vascular endothelial growth factor receptors (VEGFRs), platelet-derived growth factor receptors (PDGFRs) and fibroblast growth factor receptors (FGFRs) (IC50 values are 13 - 34 nM for VEGFR subtypes, 59 - 65 nM for PDGFR subtypes, 37 - 108 nM for FGFR subtypes). Also inhibits Flt-3, Lck, Lyn and Src (IC50 values are 25 - 200 nM). Inhibits proliferation in VEGF-stimulated endothelial cells, and PDGF-stimulated pericytes and vascular smooth muscle cells. Reduces vessel density and integrity, and inhibits tumor growth in a mouse tumor xenograft model.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|DMSO||1.08||2 with gentle warming|
Preparing Stock Solutions
The following data is based on the product molecular weight 539.64. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.02 mM||92.65 mL||463.27 mL||926.54 mL|
|0.1 mM||18.53 mL||92.65 mL||185.31 mL|
|0.2 mM||9.27 mL||46.33 mL||92.65 mL|
|1 mM||1.85 mL||9.27 mL||18.53 mL|
References are publications that support the biological activity of the product.
Hilberg et al (2008) BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res. 68 4774 PMID: 18559524
If you know of a relevant reference for Nintedanib, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Nintedanib, Nintedanib supplier, BIBF1120, angiokinase, inhibitors, inhibits, VEGFR, PDGFR, FGFR, potent, vascular, endothelial, growth, factor, platelet-derived, fibroblast, angiogenesis, VEGF, FGF, PDGF, BIBF, 1120, 7049, Tocris Bioscience
Citations for Nintedanib
Citations are publications that use Tocris products.
Currently there are no citations for Nintedanib. Do you know of a great paper that uses Nintedanib from Tocris? Please let us know.
Reviews for Nintedanib
There are currently no reviews for this product. Be the first to review Nintedanib and earn rewards!
Have you used Nintedanib?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.